These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 18467594
21. Vascular endothelial growth factors encoded by Orf virus show surprising sequence variation but have a conserved, functionally relevant structure. Mercer AA, Wise LM, Scagliarini A, McInnes CJ, Büttner M, Rziha HJ, McCaughan CA, Fleming SB, Ueda N, Nettleton PF. J Gen Virol; 2002 Nov; 83(Pt 11):2845-2855. PubMed ID: 12388821 [Abstract] [Full Text] [Related]
24. Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Jakobsson L, Kreuger J, Holmborn K, Lundin L, Eriksson I, Kjellén L, Claesson-Welsh L. Dev Cell; 2006 May; 10(5):625-34. PubMed ID: 16678777 [Abstract] [Full Text] [Related]
25. Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers. Dosch DD, Ballmer-Hofer K. FASEB J; 2010 Jan; 24(1):32-8. PubMed ID: 19726758 [Abstract] [Full Text] [Related]
26. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Man XY, Yang XH, Cai SQ, Yao YG, Zheng M. Mol Med; 2006 Jan; 12(7-8):127-36. PubMed ID: 17088944 [Abstract] [Full Text] [Related]
27. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. Bernatchez PN, Rollin S, Soker S, Sirois MG. J Cell Biochem; 2002 Jan; 85(3):629-39. PubMed ID: 11968003 [Abstract] [Full Text] [Related]
28. Major amino acid sequence variants of viral vascular endothelial growth factor are functionally equivalent during Orf virus infection of sheep skin. Wise LM, Savory LJ, Dryden NH, Whelan EM, Fleming SB, Mercer AA. Virus Res; 2007 Sep; 128(1-2):115-25. PubMed ID: 17524510 [Abstract] [Full Text] [Related]
29. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Nieminen T, Toivanen PI, Rintanen N, Heikura T, Jauhiainen S, Airenne KJ, Alitalo K, Marjomäki V, Ylä-Herttuala S. Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971 [Abstract] [Full Text] [Related]
30. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1. Colotti G, Failla CM, Lacal PM, Ungarelli M, Ruffini F, Di Micco P, Orecchia A, Morea V. FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269 [Abstract] [Full Text] [Related]
31. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands. Anisimov A, Leppänen VM, Tvorogov D, Zarkada G, Jeltsch M, Holopainen T, Kaijalainen S, Alitalo K. Sci Signal; 2013 Jul 02; 6(282):ra52. PubMed ID: 23821770 [Abstract] [Full Text] [Related]
32. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Bae DG, Kim TD, Li G, Yoon WH, Chae CB. Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646 [Abstract] [Full Text] [Related]
33. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1. Novoa A, Pellegrini-Moïse N, Bechet D, Barberi-Heyob M, Chapleur Y. Bioorg Med Chem; 2010 May 01; 18(9):3285-98. PubMed ID: 20363638 [Abstract] [Full Text] [Related]
34. Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling. Toivanen PI, Nieminen T, Laakkonen JP, Heikura T, Kaikkonen MU, Ylä-Herttuala S. Sci Rep; 2017 Jul 17; 7(1):5525. PubMed ID: 28717175 [Abstract] [Full Text] [Related]
35. Expression and regulation of neuropilins and VEGF receptors by TNF-alpha in human endothelial cells. Yang H, Li M, Chai H, Yan S, Zhang R, Yao Q, Chen C. J Surg Res; 2004 Dec 17; 122(2):249-55. PubMed ID: 15555625 [Abstract] [Full Text] [Related]
36. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice. Huusko J, Merentie M, Dijkstra MH, Ryhänen MM, Karvinen H, Rissanen TT, Vanwildemeersch M, Hedman M, Lipponen J, Heinonen SE, Eriksson U, Shibuya M, Ylä-Herttuala S. Cardiovasc Res; 2010 Apr 01; 86(1):122-30. PubMed ID: 19955220 [Abstract] [Full Text] [Related]
37. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis. Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura A, Honda Y. Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):383-8. PubMed ID: 11756651 [Abstract] [Full Text] [Related]
38. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. EMBO J; 1996 Jan 15; 15(2):290-98. PubMed ID: 8617204 [Abstract] [Full Text] [Related]
39. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholová I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Ylä-Herttuala S. Circ Res; 2003 May 30; 92(10):1098-106. PubMed ID: 12714562 [Abstract] [Full Text] [Related]
40. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Li M, Yang H, Chai H, Fisher WE, Wang X, Brunicardi FC, Yao Q, Chen C. Cancer; 2004 Nov 15; 101(10):2341-50. PubMed ID: 15476280 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]